.jpg)
1 hour ago
2
Article content
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
Collaboration Demonstrates Sequenex’s Commitment to Innovation in Medical Technology
Article content
Article content
LOS ANGELES & ATLANTA — Sequenex today announced its partnership with MedTech Innovator (MTI), the world’s largest accelerator of medical technology companies. MedTech Innovator matches healthcare industry leaders with innovative early-stage medtech companies for mentorship and support. In 2026, MedTech Innovator will select 65 startups for participation in its program.
Article content
Sequenex will work directly with select emerging companies and will also provide financial support to MedTech Innovator. Through this partnership, Sequenex will support early- and growth-stage MedTech companies by providing scalable, regulatory-ready software solutions for connected medical devices, including CGM, biosensors, and wearables. By contributing its expertise in compliant software development and leveraging its prebuilt, customizable NEX platform, Sequenex aims to accelerate development timelines, streamline regulatory readiness, and help innovators bring transformative medical technologies to market more efficiently.
Article content
Article content
“Partnering with MedTech Innovator aligns perfectly with our mission to remove barriers to innovation in connected medical devices,” said John Krlin, CTO of Sequenex. “Many startups are building groundbreaking technologies but face significant challenges when it comes to software development, integration, and regulatory readiness. We’re excited to provide the tools and expertise needed to help these companies move faster and bring impactful solutions to patients.”
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
“I’m proud of our long-standing success in discovering and supporting the world’s most promising medical technology and digital health companies,” said Paul Grand, Founder and CEO of MedTech Innovator. “Our carefully curated partners and sponsors serve a vital role in driving innovations to achieve their maximum potential, and we are thrilled to welcome Sequenex as our newest partner. Together, we look forward to improving patient outcomes and creating lasting value across the healthcare ecosystem.”
Article content
As a partner, Sequenex will engage with MedTech Innovator at every critical inflection point throughout the year. Reviewers and judges faced a formidable task, with MTI receiving a record-setting 1,800 applications for this year’s program. The top 10% of applicants advanced to the Radar Forum, held April 7–9 in Manhattan Beach and virtually, earning a coveted opportunity to pitch and engage with the MTI ecosystem.
Article content
Following final cohort selection here in May, the 2026 accelerator will officially launch at the invite-only Innovator Summit on June 3–4 in San Francisco, where companies from the latest cohorts will convene with hundreds of representatives from MTI’s partners, mentors, and alumni. The program culminates in October at the Finals Competitions, where partners reconnect with the cohort as companies showcase their progress and readiness for partnership and investment.
Article content
About Sequenex
Article content
Sequenex
Article content
Article content
is a software and product development firm focused on connected medical devices, biosensors and continuous glucose monitoring (CGM) technologies. Through its prebuilt and configurable NEX platform, Sequenex accelerates the delivery of mobile, cloud, and device-integrated applications.
Article content
Operating under an ISO 13485–certified Quality Management System, Sequenex develops medtech software in accordance with IEC 62304 and ISO 14971, supporting the full product lifecycle from prototype to clinical and commercial systems. Its approach combines a reusable software foundation with custom development to enable rapid device integration while maintaining a clear path to regulatory submission.
Article content
Article content
About MedTech Innovator
Article content
MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing over 15,000 applicants and fostering the growth of 838 graduates. Alumni have collectively raised $11 billion in follow-on funding and introduced 500+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow MTI on LinkedIn, and subscribe to its monthly newsletter.
Article content
Article content
Article content
Article content
View source version on businesswire.com:
Article content
Article content
Article content
Contacts
Article content
English (US)